We believe Genmab is in solid financial health. At the end of 2024, Genmab held DKK 9.9 billion in cash and cash equivalents. After turning profitable in 2013, the company has steadily increased its ...

Fast-evolving tech makes hospital-at-home an approaching reality. Although not everyone is a fan, the future potential is ...